NFKB1 and hepatocellular carcinoma: This chronic inflammation, often involving the activation of NF-κB and MAPK signaling pathways, creates a microenvironment conducive to hepatocellular mutagenesis and epigenetic alterations, thereby promoting HCC progression (Feitelson et al., 2022; Sivasudhan et al., 2022).